A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients
Crossref DOI link: https://doi.org/10.1208/s12248-015-9815-8
Published Online: 2015-08-19
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suleiman, Ahmed Abbas
Frechen, Sebastian
Scheffler, Matthias
Zander, Thomas
Nogova, Lucia
Kocher, Martin
Jaehde, Ulrich
Wolf, Jürgen
Fuhr, Uwe
Text and Data Mining valid from 2015-08-19